Cybin is trading at $6.51 (-5.23%) as the stock faces pressure from a broader biotech sector selloff and a weaker overall market tone.
- The decline aligns with a 2.45% drop in the broader biotech sector today, with no company-specific news catalysts reported for the move.
- Major indices, including the Nasdaq and S&P 500, are also trading lower as geopolitical tensions and risk-off sentiment weigh on the market.